SCI Case Presentation Final

Embed Size (px)

Citation preview

  • 8/4/2019 SCI Case Presentation Final

    1/44

    SPINAL CORD INJURY

    A Case Presentation

    As Partial Fulfillment for the subject NCM 102E, Care of Mother, Child, Family and group at risk with Problems

    STI College Baguio Branch

  • 8/4/2019 SCI Case Presentation Final

    2/44

    I. PATIENTS PROFILE A. BIOGRAPHIC DATA

    Name: Patient XAge: 41 Years oldAddress: Supang, Sabangan, MountainProvinceCivil Status: MarriedSex: MaleOccupation: LaborerReligious Preference/Affiliation: AnglicanHealthcare Finances: None

    Chief Complain: Inability to move his body

    B. HISTORY OF PRESENT ILLNESSThe present condition started 17 hours prior to admission when patient was riding

    on his tricycle going home when he lost control and fell to a clift in Bauko, MountainProvince. He was brought to Abatan Bauko General Hospital where first aid andintubation was done. X-ray was also done. He was then referred to Baguio GeneralHospital Medical Center for further evaluation and suggestion.

    C. PAST MEDICAL HISTORYPatient was hospitalized in Abatan Bauko General Hospital for fracture on his left

    Tibia last August 1993. No known allergies as to environmental, food and drugs asinformed by patients sister .

    D.

    FAMILY HISTORY OF ILLNESSNo known hereditary familial disease running in the family. There are no historiesof Hypertension, CVA/Stroke, Heart problems, Asthma, Mental Illness, KidneyProblems, Cancer, and Epilepsy from both parents. Neither are there known such

  • 8/4/2019 SCI Case Presentation Final

    3/44

    Social Development StatusThe patient is a 41 year old male and is married. His sister says that he

    prefers going out to look for a laboring job or sometimes farming job ratherthan going out with his friends.

    B. MENTAL AND EMOTIONAL STATUS Mental Status

    The patient is awake. He was not able to respond to touch and painfulstimuli as to anatomical structures below the level of spinal cord affectationbut was able to respond it as to anatomical structures above the level of spinalcord affectation, verbal stimuli, noise and light. He is oriented to place andpersons. He has the ability to comprehend and give signals as necessary. Hehas a Glasgow Coma Scale of 11.

    Emotional StatusHis mood and emotional response are observable through his facial

    expression. He is able to react with stressful situations which were expressedthrough changes in facial expression and crying. No stimulant or depressantwas given to alter his emotional response.

    C. ENVIRONMENTAL STATUS Safety factors

    The patient was placed in a position that his head was near the pathway of the ward which could pose as potential hazard since people (watcher, visitoror other healthcare members) might accidentally collide or sideswipe the

    weights of the halo traction of the patient. There are no side rails present in the patients bed and the space is not enough for the personal and medical thingsneeded by the patient.

  • 8/4/2019 SCI Case Presentation Final

    4/44

    D. SENSORY STATUS

    EyeHis palpebral conjunctiva is pale and his bulbar conjunctiva is white and

    clear. Both of his pupils constrict in response to light. His eyes aresymmetrical in shape.

    Auditory StatusHe is able to distinguish voice. The external ears are equally patent. The

    ears are symmetrical. He has poor ear hygiene as evidenced by the presence of earwax in the ear canal.

    NoseThe nose is symmetrical. There is a presence of Nasogastric Tube.

    Cranial Nerve assessment:Cranial nerve Assessment outcome

    CN I(Olfactory) Not TestedCN II (Optic) IntactCN V (Trigeminal) IntactCN VII (Facial) IntactCN VIII (Acoustic) IntactCN IX (Glossopharyngeal) Not TestedCN X (Vagus) Intact

    Tactile StatusThe patient was not able to feel discriminative and non-discriminative

  • 8/4/2019 SCI Case Presentation Final

    5/44

  • 8/4/2019 SCI Case Presentation Final

    6/44

    Patellar 0 0Ankle Reflex 0 0

    E. MOTOR STATUS Medical restrictions on Activity

    Patient is bedbound restricted by the presence of Halo traction and inability tomove.

    Musculoskeletal Range of Motion

    Full range of motion of both the upper and lower extremities wasachieved through passive movement with firm end feel. Range of motion for the cervical and thoracic spine was not assessed due tomedical restriction (Presence of Halo Brace).

    Muscle Strength Upper ExtremitiesHe has a Grade of 0 muscle strength for both the upper extremities.

    Muscle Strength Lower ExtremitiesHe has a Grade of 0 muscle strength for both the lower extremities.

    CerebellarUnable to assess since patients muscle for both upper and lower extremities are flaccid thereby restricting the assessment for thecerebellum function.

    Cranial nerve assessmentCranial Nerve Assessment Outcome

    CN III (Oculomotor) Intact

    CN IV (Trochlear) IntactCN V (Trigeminal) IntactCN VI (Abducens) IntactCN VII (F i l) I t t

  • 8/4/2019 SCI Case Presentation Final

    7/44

    MobilityPatient is totally dependent with functional level classification of 4. He is

    non-ambulatory and needs full assistance in activities of daily living. He isunable to do active bed mobility. Passive bed mobility is minimized due to therestriction of the halo traction.

    F. NUTRITIONAL STATUS Dietary Habits

    Patient prefers to eat vegetables and seldom eats fish and pork due tofinancial status.

    Adequacy of DietPatient uses NGT and is given osteorized food three times a day

    (breakfast, lunch and dinner). Signs of diet inadequacy cannot be assessedfully since most of the signs seen are also a typical signs for denervation andits complications. The patients sister verbalized that there is no change inphysique of the patient.

    Non-oral means of feedingThe patient uses NGT.

    G. ELIMINATION STATUS Normal Patterns

    The patients normal defecation is daily or once a day with normal amountand consistency as verbalized by her sister. He also urinates regularly and

    there were no known reports of hematuria, past stones Aids to Elimination

    Patient is immobile and consumes less amount of water which is a

  • 8/4/2019 SCI Case Presentation Final

    8/44

    pH 6.0 4.5-8.0 NormalSpecific

    Gravity:

    1.030 1.015-1.025 High; Increased concentration of dissolved

    solutes probably due to large amount of medications given. Indicative of early signsof dehydration

    Sugar: Negative Negative NormalProtein: Negative -

    TraceNegative Normal

    RBC: Toonumerous tocount

    Negative orrare

    High; Indicative of Urinary tract injury

    Method: Immunochromatography*** January 30, 2011; 12:48 A.M.

    H. FLUID AND ELECTROLYTE STATUS

    Specific gravity is 1.030 (taken last January 30, 2011) which is indicative of earlysigns of dehydration, PNSS IL X 8 was infused. Patient has decreased input of water.An IFC is connected with a range from 850 1,100 cc output per day. Currently,PNSS 1L X 16 hours with side drip of Dopamine x 5ugtts/min is infused.

    I. CIRCULATORY STATUS

    He has good skin turgor and a capillary refill of

  • 8/4/2019 SCI Case Presentation Final

    9/44

    RDW CV 12.9% 11.5 14.5 NormalRDW SD 41.4 fL 35.0 56. 0 Normal

    PLT 208 x 10^9/L 150 450 NormalMPV 10.9 fT 7. 0 11.0 NormalPDIV 15.1 15.0 17.0 NormalPCT 0.226% 0.108 0.282 Normal*** January 29, 2011

    Hematology Result form

    Parameter Result ReferenceRange

    Interpretation

    WBC 11.8 x 10^9/L 5.0 10.0 High; Indicative of infectionLYMPH 1.5 x 10^9/L 0.8 4.0 Normal MIDH 0.4 x 10^9/L 0.1 0.9 Normal GRANH 9.9 x 10^9/L 2.0 7.0 High; Indicative of infection

    LYMPH% 12.9% 20.0 45.0 Low; Indicative of low immune systemMID% 3.8% 3.0 9.0 NormalGRAN% 83.3% 40.0 75.0 High; Indicative of infectionHGB 130 g/L 140 180 Low; Indicative of defects in the balance of

    red blood cells in the blood RBC 4.50 x 10^12/L 4.00 5.50 NormalHCT 37.4% 42. 6 54.0 Low; Indicative of nutritional deficiencies of

    iron, folate, vitamin B12, and vitamin B6 MCV 83.3 fL 82.0 95.0 NormalMCH 28.8pg 27.6 31.0 NormalMCHC 374 g/L 326 360 High; Indicative of vitamin B12 deficiency

  • 8/4/2019 SCI Case Presentation Final

    10/44

    RANGELDL 1.1 mmoL/L 0 - 5.2 Normal

    Sodium 141.1 mmoL/L 136 - 145 NormalPotassium 4.0 mmoL/L .35 5.1 NormalChloride 168.7 mmoL/L 98 107 High; Indicative of respiratory

    alkalosisTriglycerides 0.59 mmoL/L 0 1.69 NormalBlood UreaNitrogen

    13.99 mmoL/L 2.56 6.49 High; Patient is in statecharacterized by decreasedeffective circulating blood volumewith decreased renalperfusion; Patient is possibly in astate of shock

    Cholesterol 2.69 mmoL/L 0 5.2 Normal;Glucose 5.41 mmoL/L 3.85 6.05 Normal;Creatinine 136.99 ummoL/L 71 115.00M High; Indicative of renal failureHDL

    Cholesterol

    1.33 umMmoL/L 53 88.4F

    1.04 1.56

    Normal

    Conventional UnitsTEST NAME RESULT UNIT REFERENCE

    RANGEInterpretation

    LDL 42.31 mg/dl 0 200 NormalSodium 141.10 mg/dl 136 145 NormalPotassium 4.00 mg/dl 3.5 5.1 NormalChloride 108.70 mg/dl 98 107 High; Indicative of respiratory

    alkalosisTriglycerides 52.44 mg/dl 0 150 NormalBlood UreaNit

    39.19 mg/dl 7.0 18.0 High; Patient is in stateh t i d b d d

  • 8/4/2019 SCI Case Presentation Final

    11/44

    Arterial Blood GasResult Normal values Interpretation

    pH 7.481 7.35 7.45 Alkalinic; Indicative of possible hyperventilationor shock

    pCO2 17.4 mmhg 35 45 mmhg Low; indicative of hyperventilation or hypoxiapO2 80.4 mmhg 80 100 mmhg NormalHCO3 12.7 mmol/L 22 26 mEq/L Low; indicative of respiratory alkalosis (which

    can be caused by hyperventilation),metabolic acidosis, shock, starvation, and orkidney failure.

    SO2 96.5 % 95 98 % NormalBE - 7.7 mmol/L -2 - +2

    -5 - +3Indicates a base deficit in the blood equivalent toan acid excess

    F1O2 60 % 60% or less NormalTHb _____g/dl No data / measurement furnished in the

    laboratory resultHct 37.4 % 39 54% Low; indicative of loss of blood

    Na 136.7 mmol/L 135-145 mmol/L NormalK 2.80 mmol/L 3.4-4.6 mmol/L LowICa .522 mmol/L*** January 30, 2011

    J. RESPIRATORY STATUS Inspection

    Color of the thorax is lighter as compared to the skin color of the face andextremities. He has no visible deformity over the anterior aspect of the thoraxarea.

  • 8/4/2019 SCI Case Presentation Final

    12/44

    Result Heavy Growth of Klebsiella Pneumoniae

    Amikacin SAmpicillin RAmoxicillin / Clavulanic Acid

    S

    Ampicillin / Sulbactan

    I

    Aztreonam SCefepime SCefexime SCefatoxime ICefuroxime RCefoxitin RCeftrioxone S

    Cytazidine IChloramphenicol RCiprofloxacin SCotrimoxazole RGentamycin SImepenem SErtapenem SMeropenem SPipracillin RPiperocillin /

    TazobactamI

  • 8/4/2019 SCI Case Presentation Final

    13/44

    K. TEMPERATURE STATUSHis temperature ranged from 36.3 to 36.6 degrees Celsius on his first week with

    elevation ranged from 37.7 to 38 degrees Celsius noted during the second week takenin axillary area. He uses a blanket as a usual measure for temperature comfort.

    L. INTEGUMENTARY STATUSHis skin is dark brown, dry and flaky. Nail beds are light brown to reddish with

    nails not trimmed. Skin is warm to touch. With bruise on medial aspect of the leftelbow, lateral aspect of the left knee, anterior proximal third of the left leg, antero-medial side of the right distal leg and hematoma on postero-lateral side of leftshoulder with approximately 1 inch in diameter, lateral side of the left hip withapproximately half inch in diameter. With clean and dry pinholes in the anterior andlateral portions of the scalp due to insertion of the pins of the halo traction. Palpablelymph node enlargement was noted on both sides of the neck. With Braden Scale asfollows:

    Date Total Score InterpretationFebruary 3, 2011 10 High Risk for Pressure SoreFebruary 4, 2011 10 High Risk for Pressure Sore February 11, 2011 10 High Risk for Pressure Sore

  • 8/4/2019 SCI Case Presentation Final

    14/44

    III. PATHOPHYSIOLOGY

    Spinal Cord Injury: PathophysiologyComplete

    Risk for infection(e.g Pneumonia)

    Spinal Shock:Loss of Somatic Sensation;Loss of visceral Sensation;

    loss of motor Function;Loss of muscle tone; loss

    of reflex activity

    Ischemia from damage / Impingement on the spinalarteries

    Compression/ directtrauma of the SpinalCord by the Bonefragments

    Fracture of vertebraeand tear of ligaments onthe cervical vertebrae(C3 C4); dislocation of facet oints

    Motor Vehicle Accident

    IneffectiveBreathing Pattern

    Microscopic hemorrhagesappear in the central graymatter & pia-arachnoidcausing reduced vascularperfusion & development of ischemic areas

  • 8/4/2019 SCI Case Presentation Final

    15/44

    Stage of Flexor Muscle SpasmIncreasing tone in flexor muscleStronger flexor response to nociceptivewhich progressively involve more proximal

    rou

    Stage of Predominant Extensor Spasticity

    Stage of alternate Flexor and ExtensorSpasticity

    Both flexor and extensor spasms occur,patient can momentarily support his weightin standin osition

    A

  • 8/4/2019 SCI Case Presentation Final

    16/44

    IV. LIST OF PROBLEMS

    1. Ineffective airway clearance related to neuromuscular dysfunction and infection secondaryto C 3 C4 jump facet.2. Ineffective breathing pattern related to musculoskeletal impairment secondary to C 3 C4

    jump facet.3. Impaired mobility related to loss of muscle function as manifested by paralysis of both

    upper and lower extremity secondary to C 3 C4 jump facet.4. Risk for impaired skin integrity related to physical immobility secondary to C 3 C4 jump

    facet.

    5. Risk for decrease cardiac output related to neurogenic shock secondary to C 3-C4 jump facet.

  • 8/4/2019 SCI Case Presentation Final

    17/44

    17

    V. NURSING CARE PLANProblem 1: Ineffective airway clearance

    ASSESSMENT EXPLANATION OFTHE PROBLEM

    OBJECTIVES INTERVENTION RATIONALE EVALUATION

    S: Ado tirumrumuar ngaterkak ditoy kwa na(pointing to theBVM) as verbalized

    by the patients sister

    O: With

    tracheostomyconnected toBVM with 8-9lpm oxygeninhalation

    Alteredrespiratory depthand rate noted

    Withtracheobronchialsecretions (dark yellow to lightgreen in color)

    With oxygensaturation of 94to 97 %

    With excessivesalivation

    Impairedcoughing reflexnoted

    Presence of

    Trauma to the C3 C4Cervical spine

    Injury to the spinal cord

    Denervationand loss of function of respiratory

    muscles

    Intubation

    Invasionand

    colonizationof

    microorganismin the

    respiratorytract

    Infection

    Inflammatory

    STO:Maintain oxygensaturation not togo below normalrange.

    LTO:Maintain optimaloxygen saturationwhile patient is inthe hospitalthroughappropriatenursingintervention

    Diagnostic: Monitoredoxygensaturation asappropriate

    Assessed skincolor andtemperature

    Monitoredairwayresistance

    IncreasingPaCo2 anddecreasingPaO2 are signsof respiratoryfailure. As thepatients beginto fail therespiratory ratedecreases andPaCO2 begin toincrease.

    To assesscyanosis whichcan occur whenat least 5 g of hemoglobin isdesaturated orcool pale skinwhich canoccursecondary to acompensatoryresponse tohypoxemia.

    Increase of resistancesignals

    Goals Met.Maintainedoxygen saturation

    Goal Partiallymet:Continue nursinginterventions asneeded

    O v e r r o

    d u c t

    i o n o

    f s a l

    i v a

    A f f e c

    t a t i o n o f

    t h e

    A N S

  • 8/4/2019 SCI Case Presentation Final

    18/44

    18

    KleibsiellaPneumoniae inbacteriologyresult

    No cyanosisnoted with skinwarm to touch

    Sputumyellowish togreenish

    Nursing Diagnosis:Ineffective airwayclearance related toneuromusculardysfunction andinfection secondaryto C 3 C4 jumpfacet.

    process

    Fever,sputum

    production

    Ineffectiveairway

    clearance

    Observedsputum colorand amount

    Checked forthe position of the patient

    Therapeutic: Suctioningdone as needed

    Provided oralcare

    accumulationof secretions of fluids

    Signs of infection couldalso be seen incolor

    Improperpositioningmay also causeabdominalcontents frompushingupwards thatmay causeairway

    To removesecretions

    impediment

    Providing oralcare maydecrease

    colonizationand increase of bacteria

    For monitoringrespiratoryinfection thatmay increase

  • 8/4/2019 SCI Case Presentation Final

    19/44

    19

    Increased fluidintake

    Collaborative: Collected andsent sputumspecimen forculture andsensitivitytesting, asappropriate

    Administeredmedication (N-acetylcysteine,terbutiline) asordered notingeffectivenessand side effects

    Educative: Emphasizedimportance of hand washingtechnique

    sputumproduction.

    Helps inliquefying andlooseningsecretions

    To promoteclearance of airwaysecretions andbronchodilationdecreasesairwayresistance

    This willdecrease if noteliminate thetransmission of microorganismto therespiratory tractwhileperforming the

    bag valve mask ventilation.

    Certainallergens canincrease mucusproductions.

  • 8/4/2019 SCI Case Presentation Final

    20/44

    20

    Explainedaboutenvironmentalfactors that canprecipitaterespiratoryproblems

  • 8/4/2019 SCI Case Presentation Final

    21/44

    21

    Problem 2: Ineffective Breathing Pattern

    ASSESSMENT EXPLANATIONOF THE

    PROBLEM

    OBJECTIVES INTERVENTION RATIONALE EVALUATION

    O: With

    tracheostomyconnected toBVM with 8-9lpm oxygeninhalation

    Paralyzedmuscles forbreathing noted

    Alteredrespiratory depthand rate noted

    With alteredinspiratory andexpiratorypressure.

    Altered chestexcursion

    Withtracheobronchialsecretions

    With oxygensaturation of 94to 97 %

    Improper bodypositioning noted

    Trauma to the C3 C4 Cervical spine

    Injury to the spinalcord

    Loss of function of phrenic nerve and

    other nervessupplying the

    respiratoryaccessory muscles

    Denervation of diaphragm and

    accessory musclesof respiration

    Paralyzeddiaphragm and

    accessory musclesof respiration

    Ineffectivebreathing pattern

    STO:

    Within 1 hour of nursing interventionthe oxygen saturationwill increase from 94-97% to 96 100%

    LTO:Maintain optimaloxygen saturationwhile patient is in thehospital throughappropriate nursingintervention

    Diagnostic: Monitoredoxygen saturationas appropriate

    Assessed skincolor andtemperature

    Therapeutic:Independent:

    Positioned thepatient withproper bodyalignment

    Increasing PaCo2and decreasingPaO2 are signs of respiratory failure.As the patientsbegin to fail therespiratory ratedecreases andPaCO2 begin toincrease.

    To assess cyanosiswhich can occurwhen at least 5 g of hemoglobin isdesaturated or coolpale skin whichcan occursecondary to acompensatoryresponse to

    hypoxemia.

    for optimal chestexcursion or lungexpansion

    Goals Met.Oxygen saturationincreased from 94-97% to 96 100%

    Goal partially met:Continue nursinginterventions asneeded

  • 8/4/2019 SCI Case Presentation Final

    22/44

    22

    Nursing Diagnosis:Ineffective breathingpattern related toNeuromusculardysfunctionsecondary to C 3 C4

    jump facet.

    Demonstratedproper rate,rhythm and depthof ambubagging

    Collaborative: Administeredmedicine(dopamine,Terbutaline) asneeded

    Educative: Emphasizedimportance of properambubagging

    Emphasized towatcher theimportance of proper bodyalignment / positioning of thepatient.

    To educate thewatcher on properambubagging

    DopamineReplaces the actionfor sympatheticnervous systemand terbutaline forbronchodilation

    This preventsexacerbation of the

    patients condition

    To educate watcheron its advantageand disadvantage

  • 8/4/2019 SCI Case Presentation Final

    23/44

    23

    Problem 3: Impaired mobility

    ASSESSMENT EXPLANATIONOF THE

    PROBLEM

    OBJECTIVES INTERVENTION RATIONALE EVALUATION

    S: haan na ngamaikuti ti baggi naas verbalized by

    patients sister

    O: With muscle

    grade of 0 onboth upper andlowerextremities

    Inability toperform ActiveRange of motionnoted

    With score of 4 totallydependent infunctionalactivities of

    daily living

    Impaired bedmobility noted

    Nursing Diagnosis:Impaired mobilityrelated to loss of muscle function as

    Trauma to the C3 C4 Cervical spine

    Injury to the spinalcord

    Loss of function of peripheral nerves

    Denervation of upper extremity,

    thoracic, abdominaland lower extremity

    muscles

    Impaired Mobility

    STO:Within 3 hours of nursing interventionwatcher willverbalizeunderstanding onimportance of health teaching andwill be able todemonstrate properperformance of activities related topreventing thecomplications of immobility.

    LTO:While patient is inthe hospital, he willbe free of complications of

    immobility, throughappropriate nursinginterventions.

    Diagnostic: Assessed for joint mobility / Range of motionand muscle tone

    Assessedeliminationstatus

    Assessed thewatchersknowledge of immobility anditscomplications

    Therapeutic: Positioned thepatient withproper bodyalignmentthroughtrochanter rollsand pillows.Supported feet

    Regularexaminations of the joint andmuscle tone willallow forprevention orearly recognitionand treatment forcontractures.

    Immobilitypromotesconstipation

    Inappropriateknowledge of the watcher willincrease the risksof complication

    To preventsecondarymusculoskeletaldeformities thatmay occur

    Goal met:Patient verbalizedunderstanding of thehealth teachings andwas able to properlydemonstrateactivities taught.

    Goals Partially met:Continue nursinginterventions asneeded

  • 8/4/2019 SCI Case Presentation Final

    24/44

    24

    manifested byparalysis of bothupper and lowerextremity secondaryto C 3 C4 jumpfacet.

    in dorsiflexedposition

    Performedpassive range of motion exerciseson all joints of the extremitiesusing slow andsmoothmovements.

    Repositionedperiodically

    (every 2 hours)to changepressure sites

    Elevated lowerextremities atregular intervals

    Collaborative: Consulted withphysicaltherapist

    To enhancecirculation,restore ormaintain muscletone and jointmobility andprevent disusecontractures anddelay muscleatrophy

    Promotesperipheral

    circulation andreduces pressure.

    To prevent bloodpooling andvenous stasisand decrease risk of thrombus

    formation

    Helpful inplanning andimplementingindividualizedexercise

  • 8/4/2019 SCI Case Presentation Final

    25/44

    25

    Educative: Instructedwatcherregardinghazards of immobility

    Emphasized towatcher theimportance of proper bodyalignment /

    positioning of the patient.

    Emphasizedimportance of passive range of motion exercises

    program.

    Informationpromotesawareness of thecomplications sothat watcher willbe able toidentify andreport signsimmediately.

    To educatewatcher on itsadvantage anddisadvantage

    To provideinformation onpreventingdelayingpossiblemusculoskeletalcomplications

  • 8/4/2019 SCI Case Presentation Final

    26/44

    26

    Problem 4: Risk for impaired skin integrity

    ASSESSMENT EXPLANATIONOF THE

    PROBLEM

    OBJECTIVES INTERVENTION RATIONALE EVALUATION

    O:

    With bradenscore of 10(high risk forpressure sores)

    Patient wearsdiaper

    Uses flatsurfaced

    mattress

    With score of 4 totallydependent infunctionalactivities of daily living

    Nursing Diagnosis:

    Risk for impairedskin integrityrelated to physicalimmobilitysecondary to C 3 C4

    jump facet.

    Trauma to the C3 C4 Cervical spine

    Injury to the spinalcord

    Denervation of bothupper extremity,thoracic , back,abdominal, and

    lower extremity

    Prolongedimmobilization

    Risk for skin

    integrity

    STO: After 1 hour of

    nursingintervention thewatcher will beable to verbalizeunderstandingof the healthteaching

    After 2 hours of nursing

    intervention thewatcher will beable to performproperprocedures onpreventingpressure sores

    LTO: While patient is

    in the hospital,there will be aminimizedemergence of pressure sores,throughappropriatenursinginterventions

    Diagnostic: Assessed abilityto move

    Assessed generalcondition of skin,specifically overbonyprominences

    Assessed foredema

    Assessed forenvironmentalmoisture

    Therapeutic: Performedpassive range of motion exercises

    Immobility is thegreatest risk factor in skinbreakdown

    Areas where skinis stretched tautlyover bonyprominences areat higher risk forbreakdown

    because thepossibility of ischemia to skinis high.

    Skin stretchedtautly overedematous tissueis at risk forimpairment

    Moisture maycontribute to skinmaceration.

    Promotesperipheralcirculation and

    Goals met:Watcher verbalizedunderstanding of thehealth teaching andwas able to performproper procedureson preventingpressure sores

    Goals Partially met:Continue nursing

    interventions asneeded

  • 8/4/2019 SCI Case Presentation Final

    27/44

    27

    and cooperationof the watcher.

    on all joints of the extremitiesusing slow andsmoothmovements.

    Demonstratedand Cleaned,dried andmoisturized skin

    Repositionedperiodically(every 2 hours)to changepressure sites

    Educative: Teach the

    watcher the

    causes of pressure ulcerdevelopment:pressure on skin,especially overbonyprominencesShearing of friction against

    reduces pressure.

    These measuresreduce skinbreakdown fromprolongedimmobility

    Because of sensorydisturbance thepatient will beunable to detect

    painful pressure.Lift shits reduceshear forceswhich furthercontribute to skinbreak down

    Thisinformationcan assist

    the watcherin findingmethods toprevent skinbreakdown.

  • 8/4/2019 SCI Case Presentation Final

    28/44

    28

    skin.

    . Teach the

    watcher toinspect the skindaily

    Skinbreakdownis anongoing,lifetimeconcern forthe patient.

  • 8/4/2019 SCI Case Presentation Final

    29/44

    29

    Problem 5: Risk for Decreased Cardiac outputASSESSMENT EXPLANATION OF THE

    PROBLEMOBJECTIVES INTERVENTION RATIONALE EVALUATION

    O: With blood

    pressure of 100/60 mmhgand pulse rate of 51 56 beats perminute

    Alert

    Capillary refill of < 2 seconds

    Nursing Diagnosis:Risk for decreasecardiac outputrelated to neurogenicshock secondary toC3-C4 jump facet.

    Trauma to the C3 C4Cervical spine

    Injury to thespinal cord

    Neurogenic shock

    Decreased Cardiac Output

    STO:Within 8 hoursof nursingintervention

    patients heartrate will increasefrom 51 56beats per minuteto 60 100 beats

    LTO:During the stayin the hospital,

    patients heartrate of 60-100beats per minuteand systolicblood pressuregreater than 90mm hg will bemaintainedthrough propernursing

    intervention

    Diagnostic: Assessed Heart

    rate and BPclosely

    Assessedperipheral pulses

    and capillaryrefill.

    Monitored intakeand output

    Therapeutic: Avoided

    elevating headof bed

    Loss of sympatheticintervention resultsin bradycardia andvasodilation of vessels below theinjury resultingfrom an unopposedParasympatheticnervous system.

    Peripheralvasodilation

    decrease venousreturn, furtherdecreasing cardiacoutput and bloodpressure.

    Changes in intakeand urine outputare an indicationsof fluid balance.

    Because of sympatheticdisruption andresultant loss of vasoconstrictortone below theinjury, head

    Goal met: patients heartrate increasedfrom 51 56beats per minuteto 65 70 beatsper minute

    Goals Partiallymet:

    Continue nursinginterventions asneeded

  • 8/4/2019 SCI Case Presentation Final

    30/44

    30

    Performedpassive range of motion exercises

    on all joints of the extremitiesusing slow andsmoothmovements.

    Collaborative: Administered

    medicine asnecessary

    Emphasizedimportance of passive range of motionexercises

    elevation willresult in furtherdrop of BP.

    Promotesperipheralcirculation

    Dopamineincreases heart rateand blood pressure

    To provideinformation aboutthe effects of PROME

  • 8/4/2019 SCI Case Presentation Final

    31/44

    31

    VI. DRUG STUDY.Tradename/Genericname

    Classification/Indication Mechanism of action

    Adverse effect/Contraindication Nursing Intervention

    Ketorolac nonsteroidalantiinflammatory drugs(NSAIDs)

    IndicationIt is for short-termmanagement of moderate to severepostoperative pain.

    Short-term

    management of

    pain (up to 5

    days)

    Ophthalmic:

    relief of ocular

    itching due to

    seasonal

    conjunctivitis

    and relief of

    post-operativeinflammation

    after cataract

    surgery.

    Inhibitsprostaglandinsynthesis by

    decreasing theactivity of theenzyme, cyclo-oxygenase,which results indecreasedformation of prostaglandinprecursors

    Percentage unknown: Renal impairment,wound bleeding (with I.M.), postoperativehematomas

    1% to 10%:

    Cardiovascular: Edema

    CNS: Drowsiness, dizziness, headache, pain

    Gastrointestinal: Nausea, dyspepsia, diarrhea,gastric ulcers, indigestion

    Local: Pain at injection site

    Miscellaneous: Diaphoresis (increased)

  • 8/4/2019 SCI Case Presentation Final

    32/44

    32

    ketorolac, aspirin, or other NSAIDs prophylaxis before major surgery suspected or confirmed

    cerebrovascular bleeding, hemorrhagic diathesis

    6 hrs to maintainserum levels andcontrol pain.

    Tradename/Genericname

    Classification/Indication Mechanism of action Adverseeffect/Contraindication

    Nursing Interventions

    Cefuroxime ANTIINFECTIVE;ANTIBIOTIC; SECOND-GENERATIONCEPHALOSPORIN

    Treatment of infections causedby staphylococci,group Bstreptococci, H.influenzae (typeA and B), E. coli,Enterobacter ,Salmonella , andKlebsiella ;

    treatment of susceptible

    infections of the lower respiratory

    tract

    otitis media

    urinary tract,

    Inhibits bacterial cellwall synthesis bybinding to one or moreof the penicillin-binding proteins(PBPs) which in turninhibits the finaltranspeptidation stepof peptidoglycansynthesis in bacterialcell walls, thusinhibiting cell wallbiosynthesis. Bacteriaeventually lyse due toongoing activity of cellwall autolytic enzymes(autolysins and murein

    hydrolases) while cellwall assembly isarrested.

    1% to 10%:

    Hematologic: Eosinophilia(7%), decreased hemoglobinand hematocrit (10%)

    Hepatic: Increasedtransaminases (4%), increasedalkaline phosphatase (2%)

    Local: Thrombophlebitis (1.7%)

  • 8/4/2019 SCI Case Presentation Final

    33/44

    33

    skin and soft tissue, bone andjoint, sepsis andgonorrhea

    cephalosporins include toxicnephropathy, cholestasis,agranulocytosis, colitis,pancytopenia, aplastic anemia,hemolytic anemia, hemorrhage,prolonged PT, encephalopathy,asterixis, neuromuscularexcitability, serum-sicknessreactions, superinfection

    Contraindication:

    Hypersensitivity to cefuroxime,any component, orcephalosporins

    potentially life-threatening complicationshould be ruled out asthe cause of diarrheaduring and afterantibiotic therapy.

    Monitor formanifestations of hypersensitivity (seeAppendix F). Discontinuedrug and report theirappearance promptly.

    Monitor I&O rates andpattern: Especiallyimportant in severely illpatients receiving highdoses. Report anysignificant changes.

  • 8/4/2019 SCI Case Presentation Final

    34/44

    34

    Tradename/Genericname

    Classification/Indication Mechanism of action Adverse effect/Contraindication Nursing Interventions

    Paracetamol Non-opioid analgesic

    Indications:

    Treatment of postoperativepain

    Treatment of mild tomoderate pain and fever;does not have antirheumaticeffects (analgesic)

    It isalso used to bringdown a hightemperature. Forthis reason,paracetamol can begiven to childrenafter vaccinationsto prevent post-immunizationpyrexia (hightemperature).

    Inhibits the synthesisof prostaglandins inthe central nervoussystem andperipherally blockspain impulsegeneration; producesantipyresis frominhibition of hypothalamic heat-regulating center

    Adverse effect:

    Percentage unknown: Mayincrease chloride, bilirubin, uricacid, glucose, ammonia, alkalinephosphatase; may decreasesodium, bicarbonate, calcium

    Contraindications:

    Patients with known G-6-PDdeficiency; hypersensitivity toacetaminophen

    Suppositories: Do not freeze

    Suspension, oral: Shake

    well before pouring a dose

    Monitor for S&S of:

    hepatotoxicity, evenwith moderateacetaminophen doses,especially inindividuals with poornutrition.

  • 8/4/2019 SCI Case Presentation Final

    35/44

    35

    Tradename/Genericname

    Classification/Indication Mechanism of action Adverse effect/Contraindication Nursing Interventions

    Terbutaline beta adrenergicreceptor agonists(stimulators)

    Indications:Bronchodilator inreversible airwayobstruction andbronchial asthma

    Relaxes bronchial smoothmuscle by action on beta 2-receptors with less effect on heart rate also inhibitsuterine activity.

    Adverse effect:

    >10%:

    Central nervous system:Nervousness, restlessness

    Neuromuscular & skeletal:Trembling

    1% to 10%:

    Cardiovascular: Tachycardia,hypertension

    Central nervous system:Dizziness, drowsiness, headache,insomnia

    Gastrointestinal: Xerostomia,nausea, vomiting, bad taste inmouth

    Neuromuscular & skeletal: Musclecramps, weakness

    Miscellaneous: Diaphoresis

  • 8/4/2019 SCI Case Presentation Final

    36/44

    36

    any component, cardiacarrhythmias associated withtachycardia, tachycardia causedby digitalis intoxication

    Tradename/Genericname

    Classification/Indication Mechanism of action Adversereaction/Contraindication

    Nursing intervention

    N -Acetylcysteine Classification: Mucolytic

    Indications: Adjunctive mucolytic

    therapy in patientswith abnormal orviscid mucoussecretions in acute andchronic

    bronchopulmonarydiseases; pulmonarycomplications of surgery and cysticfibrosis; diagnosticbronchial studies;

    antidote for acuteacetaminophen toxicity

    Exerts mucolytic actionthrough its freesulfhydryl group whichopens up the disulfidebonds in themucoproteins thuslowering mucousviscosity. The exact mechanism of action in

    acetaminophen toxicityis unknown; thought toact by providingsubstrate for conjugationwith the toxic metabolite

    Adverse reaction:

    >10%:

    Gastrointestinal:Vomiting

    Miscellaneous:Unpleasant odor during

    administration

    1% to 10%:

    Central nervous system:Drowsiness, chills

    Gastrointestinal:Stomatitis, nausea

    Local: Irritation

    Respiratory:Bronchospasm,rhinorrhea, hemoptysis

    Miscellaneous:Clamminess

    Assess patient fornausea, vomiting,and skin rash

  • 8/4/2019 SCI Case Presentation Final

    37/44

    37

  • 8/4/2019 SCI Case Presentation Final

    38/44

    38

    name/Genericname

    reaction/Contraindication intervention

    Omeprazole Classification:proton pump inhibitors (PPI)

    Indication:

    Short-term treatment of activeduodenal ulcer

    First-line therapy in treatment of heartburn or symptoms of GERD

    Short-term treatment of activebenign gastric ulcer

    GERD, severe erosiveesophagitis, poorly responsivesymptomatic GERD

    Long-term therapy: Treatment of pathologic hypersecretoryconditions (Zollinger-Ellisonsyndrome, multiple adenomas,systemic mastocytosis)

    Eradication of H. pylori withamoxicillin or metronidazole andclarithromycin

    Prilosec OTC: Treatment of frequent heartburn (2 or more daysper week)

    Unlabeled use: Posteriorlaryngitis; enhance efficacy of pancreatin for the treatment of steatorrhea in cystic fibrosis

    Suppresses gastric acidsecretion by inhibitingthe parietal cell H+/K+ATP pump. By blockingthe production of acidis decreased, and thisallows the stomach andesophagus to heal.

    Adverse reaction:

    CNS: Headache,dizziness, asthenia,vertigo, insomnia,apathy, anxiety,paresthesias, dreamabnormalities

    Dermatologic: Rash, inflammation,urticaria, pruritus,alopecia, dry skin

    GI: Diarrhea,abdominal pain, nausea,vomiting, constipation,

    dry mouth, tongueatrophy

    Respiratory: URI symptoms, cough,epistaxis

    Other: Cancer inpreclinical studies, back pain, fever

    Contraindication

    Known hypersensitivity toomeprazole

    Capsuleshould beswallowedwhole; not chewed,crushed, oropened

  • 8/4/2019 SCI Case Presentation Final

    39/44

    39

    Trade name/Generic Classification/Indication Mechanism of action Adversei /C i di i

    Nursing intervention

  • 8/4/2019 SCI Case Presentation Final

    40/44

    40

    name reaction/ContraindicationDopamine Classification:

    Adrenergic Agonist Agent

    Indication:

    Increase cardiac output

    Increase blood pressure

    Increase urine flow

    To correct hemodynamicimbalance in shock

    syndrome due to MI(cardiogenic shock),trauma, endotoxicsepticemia (septic shock),open heart surgery, andCHF.

    Stimulates bothadrenergic anddopaminergicreceptors, lowerdoses are mainlydopaminergicstimulating andproduce renal andmesentericvasodilation, higherdoses also are bothdopaminergic andbeta 1-adrenergicstimulating andproduce cardiacstimulation andrenal vasodilation;large doses stimulatealpha-adrenergicreceptors

    Adverse reaction:

    Cardiovascular:Ectopic beats,tachycardia, anginalpain, palpitations,hypotension,vasoconstriction

    Central nervoussystem: Headache

    Gastrointestinal:Nausea and vomiting

    Respiratory: Dyspnea

    Infrequent: Aberrant conduction,bradycardia,piloerection, widenedQRS complex,azotemia, elevatedpressure, polyuria,dilated pupils,ventriculararrhythmias (highdose), gangrene (highdose), hypertension,azotemia, anxiety,elevations in serumglucose (usually not

    Extravasation: Due to short half-life, withdrawal of drug is often onlynecessarytreatment.

    Use phentolamineas antidote; mix 5mg with 9 mL of NS; inject a smallamount of thisdilution intoextravasated area;blanching shouldreverseimmediately.

    Monitor site; if blanching shouldrecur, additionalinjections of phentolamine maybe needed.

    Monitor bloodpressure, pulse,peripheral pulses,and urinary output at intervalsprescribed by

    physician. Precisemeasurements areessential foraccurate titrationof dosage.

    Report the

  • 8/4/2019 SCI Case Presentation Final

    41/44

    41

    above normal limits);extravasation of dopamine can causetissue necrosis andsloughing of surrounding tissues.

    Contraindication:

    Hypersensitivity to sulfites(commercial preparationcontains sodium bisulfite);pheochromocytoma;ventricular fibrillation

    followingindicators likereduced urine flowrate in absence of hypotension;ascendingtachycardia;dysrhythmias;disproportionaterise in diastolicpressure ,signs of peripheralischemia (pallor,cyanosis, mottling,coldness,complaints of tenderness, pain,numbness, or

    burningsensation).

  • 8/4/2019 SCI Case Presentation Final

    42/44

    42

    Trade name/Genericname

    Classification/Indication Mechanism of action Adversereaction/Contraindication

    Nursing intervention

    Lactulose Classification:Ammonia detoxicant,laxative

    Indication: Adjunct in the

    prevention andtreatment of portal-systemicencephalopathy(PSE) includinghepatic andprehepatic coma(Cephylac,Cholac, Enulose,

    Evalose, Heptalacare used). treatment of

    chronicconstipation

    The bacterialdegradation of lactuloseresulting in an acidic pHinhibits the diffusion of NH3 into the blood bycausing the conversion of NH3 to NH 4+; alsoenhances the diffusion of NH3 from the blood intothe gut where conversionto NH 4+ occurs; producesan osmotic effect in thecolon with resultant distention promotingperistalsis

    Adverse reaction:

    >10%:Gastrointestinal:Flatulence,

    diarrhea ,(excessive dose)

    1% to 10%:Gastrointestinal:Abdominaldiscomfort,nausea, vomiting

    Contraindication:

    Patients withgalactosemia andrequire a low galactosediet, hypersensitivity toany component

    Dilute lactulosein water, usually60-120 mL, priorto administeringthrough a gastricor feeding tube

    Instruct the patient to:

    Take sufficient liquid with eachdose and increasefluid intakeduring the day

    Do not takeconcomitantlywith mineral oil

    Do not take forprolongedperiods in lieu of proper dietarymanagement ortreatment andunderlyingcauses of constipation

  • 8/4/2019 SCI Case Presentation Final

    43/44

    43

    Trade name/Genericname

    Classification/Indication Mechanism of action Adversereaction/Contraindication

    Nursing intervention

    Sulbactam-ampicillin Classification:Antibiotic, Penicillin

    Indication:

    Dental: Parenteralbeta-lactamase-resistant antibioticcombination to treat more severe orofacialinfections where beta-lactamase-producingstaphylococci and beta-lactamase-producingBacteroides are present

    Medical: Treatment of susceptible bacterialinfections involvedwith skin and skinstructure, intra-abdominal infections,gynecological

    infections; spectrum isthat of ampicillin plusorganisms producingbeta-lactamases suchas S. aureus , H.influenzae , E. coli,Klebsiella , Acinetobacter ,Enterobacter , and

    The addition of sulbactam, a beta-lactamase inhibitor, toampicillin extends thespectrum of ampicillin toinclude some beta-lactamase producingorganisms; inhibitsbacterial cell wallsynthesis by binding toone or more of thepenicillin bindingproteins (PBPs); which inturn inhibits the final

    transpeptidation step of peptidoglycan synthesisin bacterial cell walls,thus inhibiting cell wallbiosynthesis. Bacteriaeventually lyse due toongoing activity of cellwall autolytic enzymes(autolysins and mureinhydrolases) while cellwall assembly is

    arrested.

    Adverse reaction:

    >10%: Local: Pain at

    injection site (I.M.)1% to 10%:

    Dermatologic: Rash

    Gastrointestinal:Diarrhea

    Local: Pain at injection

    site (I.V.)

    Miscellaneous: Allergicreaction (may includeserum sickness,urticaria,bronchospasm,hypotension, etc)

  • 8/4/2019 SCI Case Presentation Final

    44/44

    44

    anaerobes vomiting, enterocolitis,pseudomembranouscolitis, hairy tongue,dysuria, vaginitis,leukopenia,neutropenia,thrombocytopenia,

    decreased hemoglobinand hematocrit,increased liverenzymes,thrombophlebitis,increasedBUN/creatinine,interstitial nephritis(rar

    Contraindication:Hypersensitivity toampicillin, sulbactam orany component, orpenicillins

    Type of I.V fluids Components of I.V fluid Class of I.V fluid Effect

    Normal saline solution Sodium chloride, water, glucose isotonic mimics the bodiesnatural blood salt concentration andcontains 0.9% salt solution

    prevent dehydration inpatients